文献速递胸部肿瘤放疗姑息放疗与转移瘤

肺癌放疗后早期与晚期CTCAE及患者报告结局:REQUITE队列的性别分层描述性分析

Early and late CTCAE and patient-reported outcomes following lung cancer radiotherapy: A sex-stratified descriptive analysis from the REQUITE cohort.
PubMed 文献 · Clin Transl Radiat Oncol · 2026-08-20

基于REQUITE多中心前瞻性队列,分析530例2014–2017年接受根治性放疗的肺癌患者,采用CTCAE v4.0记录21类不良事件并结合患者报告结局。12个月时可评估309例,肺部不良事件最常见(40%为≥2级),女性食管炎及吞咽困难、胸壁疼痛报告率更高,男性心脏不良事件更频繁,疲劳和体力活动下降持续存在。

要点

  • 肺部不良事件最常见,12个月时40%为≥2级,主要为呼吸困难和咳嗽。
  • 女性食管炎发生率更高,更常报告吞咽困难和胸壁疼痛;男性心脏不良事件更频繁。
  • 患者报告结局显示疲劳持续和体力活动减少,尤其在女性中。

核心结论

  • REQUITE-Lung队列提供了肺癌放疗相关不良事件的前瞻性真实世界数据,描述了按性别、年龄和治疗特征分布的不良事件模式。
  • 这些发现具有假设生成性,可能支持未来在独立和汇总数据集中的验证。

研究设计与样本

  • 多中心前瞻性队列REQUITE研究,纳入530例2014–2017年在欧洲和美国16个中心接受根治性放疗(序贯或同步放化疗或SBRT)的肺癌患者。

主要发现

  • 12个月时可评估309例,其中151例随访超过一年。
  • 肺部不良事件最常见,40%为≥2级,主要为呼吸困难和咳嗽。
  • 女性食管炎发生率更高,更常报告吞咽困难和胸壁疼痛;男性心脏不良事件更频繁。
  • 探索性亚组分析发现,SBRT后≥3级肺部不良事件存在显著性别差异,临床I–II期和年龄>70岁患者中总体≥2级食管不良事件存在显著性别差异。
  • 患者报告结局显示疲劳持续和体力活动减少,尤其在女性中;症状患病率和严重程度因性别、年龄、治疗方式、吸烟状态和临床分期而异。

临床怎么用

  • 临床随访中应关注肺癌放疗后肺部不良事件(呼吸困难和咳嗽),并注意女性食管炎、吞咽困难和胸壁疼痛的报告。
  • 对男性患者需警惕心脏不良事件,对女性患者需关注持续疲劳和体力活动下降。

局限性

  • 12个月时可评估309例,仅151例随访超过一年,样本量随随访时间减少。
  • 研究为描述性分析,亚组分析为探索性,发现具有假设生成性,需独立验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Long-term prospective data on lung cancer patients treated with radiotherapy are limited, restricting understanding of outcomes and sex-specific characteristics. The multicentre REQUITE study provides standardized follow-up data from an international cohort. METHODS: We analysed longitudinal data from 530 lung cancer patients treated with radical radiotherapy (sequential or concurrent chemoradiotherapy, or stereotactic body radiation therapy [SBRT]) between 2014 and 2017 at 16 centres in Europe and the USA. Healthcare professionals prospectively recorded 21 pulmonary, oesophageal, neurological, cardiac, and skin adverse events using CTCAE v4.0. Patient-reported outcomes assessed symptoms, quality-of-life, fatigue, and physical activity. Adverse event incidence was stratified by sex, radiotherapy technique, chemotherapy administration, smoking status, and other clinical factors. RESULTS: At 12 months, 309 patients were evaluable, with 151 having follow-up beyond one year. Pulmonary adverse events were most frequent (40% grade ≥ 2), mainly dyspnoea and cough. Women had higher rates of oesophagitis, and more frequently reported dysphagia, and chest wall pain, while men experienced a higher frequency of cardiac adverse events. Exploratory subgroup analyses identified significant sex-related differences in grade ≥ 3 pulmonary adverse events following SBRT and in overall grade ≥ 2 oesophageal adverse events among patients with clinical stage I-II and those aged >70 years. Patient-reported outcomes showed persistent fatigue and reduced physical activity, particularly in females. Symptom prevalence and severity varied by sex, age, treatment modality, smoking status, and clinical stage. CONCLUSION: The REQUITE-Lung cohort provides prospectively collected real-world data on radiotherapy-related adverse events in lung cancer patients. This study describes patterns of adverse events and patient-reported outcomes according to sex, age, and treatment characteristics. These findings are hypothesis-generating and may support future validation in independent and pooled datasets.

来源:Clin Transl Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Aguado-Barrera ME, Calvo-Crespo P, Taboada-Valladares B, et al. Early and late CTCAE and patient-reported outcomes following lung cancer radiotherapy: A sex-stratified descriptive analysis from the REQUITE cohort. Clin Transl Radiat Oncol. 2026. PMID: 42699144. doi:10.1016/j.ctro.2026.101265

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。